Drug Discovery Solutions
-
Mammalian Cell Culture: Process R&D Services
Lonza’s global R&D center for mammalian cell processes is based in Slough, UK alongside a custom manufacturing facility. Lonza undertakes highly specialized development and manufacturing services for the pharmaceutical and biotechnology industries. Read more about Lonza’s complete range of R&D Services and an array of technologies and skills to best match their customers’ requirements for all stages of product development.
-
PUREplatform PUREcoli, A Pure Microbial Strain For Protein Production
3/17/2023
PUREplatform offers a platform, a premium strain, and cutting-edge screening, which together yield optimal protein expression that is uniquely tailored to each project.
-
Container Closure Integrity Testing
Lonza’s Drug Product Services delivers a holistic approach to DP development that prevents problems early and produces a product that is fit for purpose.
-
Surfactant Analysis Services
Successful drug product development should integrate formulation, manufacturing process, primary packaging, device and delivery to the patient. Lonza’s Drug Product Services (DPS) offering delivers a holistic approach to DP development that anticipates and prevents problems early, and ensures the result is a product that is fit for purpose.
-
Developability Assessment
2/16/2021
The developability evaluation comprises in silico analysis as well as a series of in vitro assays for the drug candidates, so to provide information about the integrity, purity, aggregation, thermostability, charge heterogeneity, glycosylation, poly-reactivity, potency, stability over low pH and accelerated storage conditions, and potential PKPD profile.
-
Integrated Drug Discovery
7/1/2023
Finding a partner with integrated services is crucial for accelerating timelines and accessing solutions with comprehensive expertise, all while removing risk from the drug product lifecycle.
-
Live Biotherapeutics And Next Gen Manufacturing
10/5/2023
With services to develop and scale up Probiotics, Postbiotics and Microbial Therapeutics, explore how Sacco System’s capabilities can help take your drug product to market safely and efficiently.
-
Particle Control In Biopharmaceuticals
Successful drug product development should integrate formulation, manufacturing process, primary packaging, device and delivery to the patient. Lonza’s Drug Product Services (DPS) offering delivers a holistic approach to DP development that anticipates and prevents problems early, and ensures the result is a product that is fit for purpose.
-
ADCs: From Design To Development
1/4/2024
Explore how a CDMO with specialized teams can support running different stages in parallel to facilitate data sharing and clear communication, ultimately taking your ADC from design to development.
-
Potency Assay Development - Creating Potential Together
It is necessary to achieve a well-designed and developed potency assay as it is the only analytical technique that can demonstrate the biological mechanism of action and the link to clinical efficacy.